Country Reports — Market Intelligence by Geography

Markets NXT — A Montclaire & Stein Venture

A Century of Global Intelligence Behind Every Report

Markets NXT builds on a legacy dating to the early 1900s, when economists Edgar Montclaire and Johann Stein began advising enterprises across Europe and North America on industrial expansion and globalization. Over more than a century, Montclaire & Stein accumulated institutional knowledge spanning economic intelligence and market dynamics across geographies — forming the analytical foundation behind every report we publish today.

Why Country-Level Intelligence Matters

Global markets are not uniform. Regulatory environments, consumer behavior, industrial composition, and competitive dynamics differ significantly by country. Country-specific research helps businesses:

  • Accurately size and forecast a market within a defined geography
  • Understand local demand drivers, supply chains, and competition
  • Navigate country-specific regulatory and policy frameworks
  • Identify entry points, opportunities, and risk factors at a national level

What Our Country Reports Cover

Each report delivers institutional-grade intelligence across: market sizing and forecasting, industry segmentation, competitive landscape, regulatory environment, macroeconomic context, and strategic recommendations — all grounded in conservative, multi-source validated methodology.

Institutional Rigour at the Most Competitive Pricing

Markets NXT offers country-specific research at the most competitive pricing in the industry, without compromising analytical standards. Our reports serve growth-stage businesses, investment firms, and consulting teams that need board-level intelligence without enterprise-level costs.

Explore Reports by Country

Browse and filter below to find market research reports for the country of your interest. Coverage spans North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

Showing 21 - 30 of 344 reports

U.S. Spinal Cord Stimulator Market Size, Share & Forecast 2026–2032

Report Highlights Market Size 2024: USD 2.9 billion Market Size 2032: USD 4.6 billion CAGR: 6.0% Market Definition: Revenue from implantable spinal cord stimulator systems sold or implanted in the United States, including pulse generators, leads, extensions, and programming hardware. Coverage includes rechargeable, non-rechargeable, and … Read More
Published November 2026

U.S. Asthma COPD Drugs Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Asthma and COPD Drugs Market Size 2024: US$21.4 billion Market Size 2032: US$31.9 billion CAGR: 5.1% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Biologics Drive Import Growth: Biologic add-on therapies now drive fastest … Read More
Published November 2026

U.S. Biopsy Devices Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Biopsy Devices Market Size 2024: USD 2.36 billion Market Size 2032: USD 3.49 billion CAGR: 5.0% Base Year: 2025 Forecast Period: 2026-2032 Analyst Findings and Recommendations Finding 01 — Reimbursement Tiers Set Pricing: CMS codes 19081 through 19086 tie … Read More
Published November 2026

U.S. Clinical Data Analytics Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Clinical Data Analytics Market Size 2024: USD 8.6 billion Market Size 2032: USD 19.3 billion CAGR: 10.6% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Data Asset Control Concentrates: Flatiron Health, owned by Roche … Read More
Published November 2026

U.S. Delirium Market Size, Share & Forecast 2026–2032

Report Highlights Market Size 2024: USD 2.4 billion Market Size 2032: USD 3.6 billion CAGR: 5.2% Market Definition: U.S. spending on pharmacological agents, neuromonitoring devices, digital screening software, and non-pharmacological programs used to prevent, detect, and treat delirium across acute, post-acute, and long-term care. Excludes … Read More
Published November 2026

U.S. Genitourinary Drugs Market Size, Share & Forecast 2026–2032

Report Highlights Market Size 2024: USD 14.8 billion Market Size 2032: USD 21.3 billion CAGR: 4.6% Market Definition: Net revenue from prescription drugs treating erectile dysfunction, benign prostatic hyperplasia, overactive bladder, urinary tract infection, and related genitourinary conditions across U.S. retail, mail-order, specialty, and telehealth … Read More
Published November 2026

U.S. Liver Biopsy Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Liver Biopsy Market Size 2024: USD 412.6 million Market Size 2032: USD 647.7 million CAGR: 5.8% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Fibrosis Staging Displacement Accelerating: Echosens' FibroScan transient elastography, billed under … Read More
Published November 2026

U.S. Orthopedic Trauma Devices Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Orthopedic Trauma Devices Market Size 2024: USD 4.82 billion Market Size 2032: USD 7.12 billion CAGR: 5.0% Base Year: 2025 Forecast Period: 2026-2032 Analyst Findings and Recommendations Finding 01 — ASC Upper-Extremity Migration: Distal radius fixation is migrating to … Read More
Published November 2026

U.S. Cardiopulmonary Disease Diagnostics Treatment Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: U.S. Cardiopulmonary Disease Diagnostics and Treatment, covering cardiac and pulmonary diagnostic equipment, implantable therapy devices, and related pharmaceutical and consumable supply chains Market Size 2024: USD 118.4 billion Market Size 2032: USD 177.0 billion CAGR: 5.1% Base Year: 2025 … Read More
Published November 2026

U.S. Corneal Surgery Devices Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Corneal Surgery Devices Market Size 2024: USD 1.42 billion Market Size 2032: USD 2.27 billion CAGR: 6.2% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Donor Tissue Bottleneck Persists: Eye banks supply the U.S. … Read More
Published November 2026